Yüklüyor......
Metformin as a Potential Neuroprotective Agent in Prodromal Parkinson's Disease—Viewpoint
To date, there are no clinically effective neuroprotective or disease-modifying treatments that can halt Parkinson's disease (PD) progression. The current clinical approach focuses on symptomatic management. This failure may relate to the complex neurobiology underpinning the development of PD...
Kaydedildi:
| Yayımlandı: | Front Neurol |
|---|---|
| Asıl Yazarlar: | , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Frontiers Media S.A.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7304367/ https://ncbi.nlm.nih.gov/pubmed/32595595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00556 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|